Medherant Announces Positive Results for Initial Phase 1 Clinical Trial of Testosterone Patch for Women

Sionna Therapeutics Announces Initiation of PreciSION CF Phase 2a Trial Evaluating NBD1 Stabilizer, SION-719, When Added to Standard of Care in Participants with Cystic Fibrosis

Sionna Therapeutics has initiated its Phase 2a PreciSION CF trial evaluating SION-719, the first NBD1 stabilizer, in combination with Trikafta in people with cystic fibrosis. The study marks the first time an NBD1 stabilizer has been tested alongside the current standard of care, representing a key step toward validating NBD1 as a novel, synergistic mechanism to further improve CFTR function.

KLAS Emerging Solutions Report: Ambience Healthcare Ranked #1 in Improving Clinician Experience, Top 3 in Both Improving Patient Experience and Improving Outcomes

KLIFO Receives Regulatory Approval for New State-of-the-Art Clinical Trial Supply Facility in Copenhagen

Biopharma PEG Expands Monodispersed Azide-PEG Portfolio to Advance Bioconjugation and Drug Delivery Research

Biopharma PEG Scientific Inc. has expanded its portfolio of monodispersed azide-PEG derivatives to support bioconjugation, ADC linker development, and nanoparticle surface modification. The company now offers GMP-standard manufacturing from milligram to 100-kilogram scale, ensuring consistency and scalability for research and preclinical use.

Enamine contributes to the discovery of promising broad-spectrum coronavirus antiviral

Open-science research initiative, COVID Moonshot and the AI-driven Structure-enabled Antiviral Platform (ASAP) consortium, delivered a promising pre-clinical candidate 2,000 new compounds generated for the programme are now available from Enamine’s catalogue

Pillar VC, ARIA, and DSIT Announce Inaugural Encode: AI for Science Fellows

18 Encode AI fellows will be embedded into cutting-edge scientific labs across the UK

FDB Announces First MCP Server for AI Clinical Decision Support and Other Medication Workflow Automation

FDB Announces First MCP Server for AI Clinical Decision Support and Other Medication Workflow Automation

Brook.ai Secures $28 Million in Series B Funding, Led by UMass Memorial Health and Morningside, to Accelerate Next Phase of Growth and Innovation in Remote Care

Brook.ai Secures $28 Million in Series B Funding, Led by UMass Memorial Health and Morningside, to Accelerate Next Phase of Growth and Innovation in Remote Care

DPYD Safety Update: Reducing the Risk of Critical or Fatal Chemotherapy Side Effects

Ensera launches as new brand identity for SteriPack

eClinical Solutions and ZS Announce Strategic Partnership to Deliver a New Industry Standard for RBQM

Collaboration unites elluminate platform technology and ZS RBQM expertise to offer a fully integrated, data-driven approach to risk and quality management

InformedDNA and Know Your Lemons Foundation® Expand Access to Early Detection and Genetic Counseling for Breast Cancer

InformedDNA and Know Your Lemons are combining their expertise in oncology, patient education, precision medicine and genetic counseling to provide personalized screening and care recommendations for those at various risks for breast cancer. The partnership extends Know Your Lemons’ mission to provide breast cancer education and guidance.

Aylward Enterprises Highlights Bulk Handling Capabilities with Bulk Product Conveyor and BPC Sorter

Aylward Enterprises, a recognized leader in oral solid dose (OSD) packaging automation, highlights two complementary bulk handling solutions engineered to optimize product transfer and inspection prior to feeding: the Bulk Product Conveyor (BPC) and the BPC Sorter. Designed to seamlessly integrate with upstream feeding systems, these accessories deliver reliable product transport, chip removal, and automated inspection, helping manufacturers maintain high throughput and product quality across pharmaceutical, nutraceutical, and healthcare operations.

Proscia to Broaden Pathology AI Capabilities with Biomarker Detection for Skin Tissue

Proscia®, a pathology AI company, will add AI biomarker detection for skin tissue to its Concentriq® software platform, empowering pathologists to drive efficiency and precision. Powered by Primaa, Cleo Skin* will strengthen Concentriq's lead in offering the industry’s broadest portfolio of AI solutions on a single platform. 

Syncell Expands European Market Presence to Advance Disease Research and Drug Discovery

Syncell Inc. announced the deployment of its commercial Microscoop® Mint technology at two of Europe’s foremost research institutes.

CN Bio launches all-in-one Organ-on-a-chip system, PhysioMimix® Core

• Combines single-organ, multi-organ, and higher-throughput configurations within one scalable platform • Fully compatible with existing PhysioMimix accessories, validated protocols, consumables, and organ model kits for seamless workflow integration

Quotient Sciences and Biorasi partner to accelerate early phase clinical trials to patient proof-of-concept

SPT Labtech and 10x Genomics Partner to Automate Single Cell Workflows

Clustermarket rebrands to Calira and secures industry veteran to capitalise on demand for optimised R&D lab operations

Clustermarket, the lab equipment scheduling platform, has today announced it is rebranding to Calira and welcoming non-executive director and investor Edmund Wilson, co-founder and former CEO of Titian Software (now Cenevo), to capitalise on increasing enterprise demand for optimising lab operations.